162 related articles for article (PubMed ID: 35008203)
1. DNA Methylation in
Katzendorn O; Peters I; Dubrowinskaja N; Moog JM; Reese C; Tezval H; Faraj Tabrizi P; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008203
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS).
Serth J; Peters I; Katzendorn O; Dang TN; Moog J; Balli Z; Reese C; Hennenlotter J; Grote A; Lafos M; Tezval H; Kuczyk MA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232491
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
[TBL] [Abstract][Full Text] [Related]
4. GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
Peters I; Eggers H; Atschekzei F; Hennenlotter J; Waalkes S; Tränkenschuh W; Grosshennig A; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
BJU Int; 2012 Jul; 110(2 Pt 2):E144-52. PubMed ID: 22289415
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
[TBL] [Abstract][Full Text] [Related]
6. Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue.
Serth J; Peters I; Dubrowinskaja N; Reese C; Albrecht K; Klintschar M; Lafos M; Grote A; Becker A; Hennenlotter J; Stenzl A; Tezval H; Kuczyk MA
Clin Epigenetics; 2020 Feb; 12(1):33. PubMed ID: 32070431
[TBL] [Abstract][Full Text] [Related]
7. Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes.
Serth J; Peters I; Hill B; Hübscher T; Hennenlotter J; Klintschar M; Kuczyk MA
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628134
[TBL] [Abstract][Full Text] [Related]
8. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
[TBL] [Abstract][Full Text] [Related]
9. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
Xu L; He J; Cai Q; Li M; Pu X; Guo Y
Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.
Greco SA; Chia J; Inglis KJ; Cozzi SJ; Ramsnes I; Buttenshaw RL; Spring KJ; Boyle GM; Worthley DL; Leggett BA; Whitehall VL
BMC Cancer; 2010 Sep; 10():494. PubMed ID: 20846368
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.
Dubrowinskaja N; Gebauer K; Peters I; Hennenlotter J; Abbas M; Scherer R; Tezval H; Merseburger AS; Stenzl A; Grünwald V; Kuczyk MA; Serth J
Cancer Med; 2014 Apr; 3(2):300-9. PubMed ID: 24464810
[TBL] [Abstract][Full Text] [Related]
14. Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
Arai E; Chiku S; Mori T; Gotoh M; Nakagawa T; Fujimoto H; Kanai Y
Carcinogenesis; 2012 Aug; 33(8):1487-93. PubMed ID: 22610075
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.
Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J
Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210
[TBL] [Abstract][Full Text] [Related]
16. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.
Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic alterations during renal carcinogenesis.
Arai E; Kanai Y
Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
[TBL] [Abstract][Full Text] [Related]
18. Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues.
Arai E; Kanai Y; Ushijima S; Fujimoto H; Mukai K; Hirohashi S
Int J Cancer; 2006 Jul; 119(2):288-96. PubMed ID: 16453286
[TBL] [Abstract][Full Text] [Related]
19. Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma.
Gebauer K; Peters I; Dubrowinskaja N; Hennenlotter J; Abbas M; Scherer R; Tezval H; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Br J Cancer; 2013 Jan; 108(1):131-8. PubMed ID: 23321515
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome.
Arai E; Ushijima S; Fujimoto H; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Carcinogenesis; 2009 Feb; 30(2):214-21. PubMed ID: 19037089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
